These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7868866)

  • 1. Actions of angiotensin II on cerebral blood flow autoregulation in health and disease.
    Squire IB
    J Hypertens; 1994 Nov; 12(11):1203-8. PubMed ID: 7868866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoregulation of cerebral circulation: adaptation to hypertension and re-adaptation in response to antihypertensive treatment].
    Pieniazek W; Dimitrow PP
    Przegl Lek; 2006; 63(8):688-90. PubMed ID: 17441384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin in autoregulation of cerebral blood flow.
    Paulson OB; Waldemar G; Andersen AR; Barry DI; Pedersen EV; Schmidt JF; Vorstrup S
    Circulation; 1988 Jun; 77(6 Pt 2):I55-8. PubMed ID: 3286046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of captopril on cerebral blood flow in hypertensive rats before and after cerebral ischemia].
    Adzhienko LM
    Eksp Klin Farmakol; 1999; 62(5):18-20. PubMed ID: 10572745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of captopril and enalapril on the cerebral circulation of normotensive rats].
    Adzhienko LM; Isaak AD
    Eksp Klin Farmakol; 1999; 62(3):18-9. PubMed ID: 10439941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.
    Fyhrquist F; Metsärinne K; Tikkanen I
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S19-24. PubMed ID: 8583476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of angiotensin II on the cerebral circulation and function].
    Nagao T
    Nihon Rinsho; 1999 May; 57(5):1096-102. PubMed ID: 10361441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
    Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
    Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis].
    Egido J; Ruiz-Ortega M; Muñoz-García B; Martín-Ventura JL; Blanco-Colio LM
    Nefrologia; 2005; 25 Suppl 2():117-28. PubMed ID: 16050414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
    Weber MA
    Rev Cardiovasc Med; 2002; 3(4):183-91. PubMed ID: 12556752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure.
    Fuchs FD
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):771-5. PubMed ID: 15350178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasoactive therapy on cerebral circulation.
    Rhoney DH; Liu-DeRyke X
    Crit Care Clin; 2006 Apr; 22(2):221-43, vi. PubMed ID: 16677997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system--from Tigerstedt to Goldblatt to ACE inhibition and beyond.
    Atlas SA; Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):81-6. PubMed ID: 9520510
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
    Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
    Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
    Leary AC; MacDonald TM
    Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.